# FDA Inspection 800093 - AstraZeneca Pharmaceuticals LP - September 21, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/fde08717-9676-4f37-ab61-6645a32e4d4b/
Source feed: FDA_Inspections

> FDA Inspection 800093 for AstraZeneca Pharmaceuticals LP on September 21, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 800093
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2012-09-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1197584 - 2023-01-19](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/8f38115c-8fc4-487e-a8a4-911759c96220/)
- [FDA Inspection 1062666 - 2018-08-17](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/e8cc1fea-3abb-4c6e-ba1a-26aa0b81097f/)
- [FDA Inspection 936980 - 2015-07-24](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/38f13f8b-b1dc-4dd9-92eb-01a857cfa3e2/)
- [FDA Inspection 590281 - 2009-06-18](https://www.globalkeysolutions.net/api/records/fda_inspections/astrazeneca-pharmaceuticals-lp/107a5153-cd5b-43fa-942e-545e1967efd0/)

Company: https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/6f9abb75-9352-43df-b761-026089396fa3

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c